XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condsensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income $ 49,946 $ 50,708
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion, net 2,504 1,696
Provision for credit losses 4,690 1,013
Income from accretion of merchant fees and discount associated with receivables purchases (79,666) (82,680)
Changes in fair value of loans 345,422 327,651
Amortization of debt issuance costs 5,289 2,904
Stock-based compensation costs 1,990 1,962
Lease liability payments (1,499) (361)
Changes in assets and liabilities:    
Increase in uncollected fees on earning assets (110,557) (113,268)
Increase in income tax liability 11,302 14,951
Increase in accounts payable and accrued expenses 8,996 3,950
Other (3,978) 1,261
Net cash provided by operating activities 234,439 209,787
Investing activities    
Proceeds from recoveries on charged off receivables 23,449 30,101
Investments in earning assets (1,238,058) (1,192,213)
Proceeds from earning assets 949,988 924,499
Purchases and development of property (131) (3,798)
Net cash used in investing activities (264,752) (241,411)
Financing activities    
Noncontrolling interests contributions 3 4
Noncontrolling interests distributions (148) 0
Proceeds from issuance of Series B preferred stock, net of issuance costs 1,071 1,112
Preferred stock and preferred unit dividends (12,500) (12,429)
Proceeds from exercise of stock options 45 59
Purchase and retirement of outstanding stock (1,816) (4,964)
Proceeds from issuance of Senior notes, net of issuance costs 54,559 0
Proceeds from borrowings 423,898 252,212
Repayment of borrowings (411,289) (243,159)
Net cash provided by (used for) financing activities 53,823 (7,165)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 0 4
Net increase (decrease) in cash and cash equivalents and restricted cash 23,510 (38,785)
Cash and cash equivalents and restricted cash at beginning of period 383,653 433,192
Cash and cash equivalents and restricted cash at end of period 407,163 394,407
Supplemental cash flow information    
Cash paid for interest 65,181 45,501
Net cash income tax payments 176 436
Accretion of discount associated with issuance of subsidiary equity 150 150
Decrease in accrued and unpaid preferred stock and preferred unit dividends $ (50) $ (47)